WHO ARE THE CONSUMERS OF EMERGING PSYCHOACTIVE SUBSTANCES? A TYPOLOGY OF AUSTRALIAN ECSTASY AND RELATED DRUG USERS

被引：0
|
作者：
Bruno, Raimondo [1 ]
Matthews, Allison J. [1 ]
Alati, Rosa [2 ,3 ]
Lenton, Simon [4 ]
Roxburgh, Amanda [5 ]
Dunn, Matthew [6 ]
Van Buskirk, Joe [5 ]
Burns, Lucy [5 ]
机构：
[1] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia
[2] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
[3] Univ Queensland, Ctr Youth Subst Abuse Res, Brisbane, Qld, Australia
[4] Curtin Univ, Natl Drug Res Inst, Perth, WA 6845, Australia
[5] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
[6] Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia
来源：
DRUG AND ALCOHOL REVIEW | 2013年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [21] EMERGING PSYCHOACTIVE SUBSTANCES (EPS) IN AUSTRALIA: WHAT'S AVAILABLE, WHAT'S BEING USED, AND WHO IS USING THEM?
    Bruno, Raimondo
    Matthews, Allison
    Poesiat, Rosalie
    Sindicich, Natasha
    DRUG AND ALCOHOL REVIEW, 2011, 30 : 15 - 16
  • [22] RECURRENT DRUG-RELATED PROBLEMS AMONG REGULAR ECSTASY USERS (REU) AND ASSOCIATED DEMOGRAPHICS AND DRUG USE PATTERNS
    Scott, Laura
    Burns, Lucy
    DRUG AND ALCOHOL REVIEW, 2010, 29 : 67 - 68
  • [23] Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan
    Yeh, Hsin-Tzu
    Chen, Hsien-Yi
    Liu, Sung-Wei
    Weng, Te-, I
    Fang, Cheng-Chung
    Yu, Jiun-Hao
    Chen, Yen-Chia
    Su, Yu-Jang
    Gao, Shi-Ying
    Lin, Chih-Chuan
    TOXICS, 2022, 10 (07)
  • [24] Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
    Giorgetti, Arianna
    Pascali, Jennifer P.
    Fais, Paolo
    Pelletti, Guido
    Gabbin, Andrea
    Franchetti, Giorgia
    Cecchetto, Giovanni
    Viel, Guido
    LIFE-BASEL, 2021, 11 (05):
  • [25] Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users
    Jörg Daumann
    Thomas Fischermann
    Karsten Heekeren
    Katharina Henke
    Armin Thron
    Euphrosyne Gouzoulis-Mayfrank
    Psychopharmacology, 2005, 180 : 607 - 611
  • [26] Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-Methylenedioxymethamphetamine) users
    Daumann, J
    Fischermann, T
    Heekeren, K
    Henke, K
    Thron, A
    Gouzoulis-Mayfrank, E
    PSYCHOPHARMACOLOGY, 2005, 180 (04) : 607 - 611
  • [27] Number and type of substances in alcohol and drug-related completed suicides in an Australian sample
    Oei, Tian P. S.
    Foong, Teresa
    Casey, Leanne M.
    CRISIS-THE JOURNAL OF CRISIS INTERVENTION AND SUICIDE PREVENTION, 2006, 27 (02) : 72 - 76
  • [28] DRUG CHECKING AND OTHER HARM REDUCTION BEHAVIOURS REPORTED BY PEOPLE WHO USE ECSTASY: FINDINGS FROM THE ECSTASY AND RELATED DRUGS REPORTING SYSTEM 2019
    Peacock, Amy
    Bruno, Raimondo
    Barratt, Monica
    Sutherland, Rachel
    Hughes, Caitlin
    Gibbs, Daisy
    Grigg, Jodie
    Uporova, Julia
    Karlsson, Antonia
    Kelly, Georgia
    Dietze, Paul M.
    Salom, Caroline
    Lenton, Simon
    Degenhardt, Louisa
    Farrell, Michael
    Ezard, Nadine
    DRUG AND ALCOHOL REVIEW, 2019, 38 : S81 - S81
  • [29] NOVEL PSYCHOACTIVE SUBSTANCES AND MENTAL HEALTH: CHANGES IN DRUG-RELATED PSYCHIATRIC ADMISSIONS ASSOCIATED WITH THE ARRIVAL AND DEPARTURE OF HEADSHOPS
    Smyth, Bobby P.
    Daly, Antoinette
    Clarke, Mary
    Craig, Sarah
    Cullen, Walter
    DRUG AND ALCOHOL REVIEW, 2016, 35 : 68 - 69
  • [30] Do users of new psychoactive substances take what they think they take? An overview of drug product contents analysed within the Swedish STRIDA project
    Backberg, Matilda
    Lindeman, Erik
    Beck, Olof
    Jonsson, Karl-Henrik
    Helander, Anders
    CLINICAL TOXICOLOGY, 2015, 53 (04) : 357 - 358
12345